Abstract Body

Background: Th17 cells maintain gut homeostasis by co-ordinating a variety of innate and adaptive immune responses. HIV infection causes a profound depletion of gut Th17 cells, contributing to loss of mucosal barrier function and microbial translocation, thus driving systemic immune activation. Despite normalization of circulating CD4+ T cell counts with highly active antiretroviral therapy (HAART), Th17 frequency and function often remain impaired. The IL-12 family cytokine member IL-23 plays a crucial role in maintaining normal Th17 cell function. We hypothesize that HIV inhibits IL-23 signalling in Th17 cells, resulting in Th17 dysfunction. Methodology: Th17 cells were isolated from peripheral blood of HIV-seronegative donors by magnetic selection and infected with HIVCS204, a dual-tropic clinical isolate for 24 hours. Expression of IL-17 was examined by ELISA and flow cytometry. Levels of Th17-associated transcription factors STAT3 and retinoic acid orphan receptor C (RORC) mRNA expressed in response to IL-23 stimulation were quantified by qRT-PCR. Phosphorylation of STAT3, the primary transducer of IL-23 signalling, in response to IL-23 stimulation was assessed by flow cytometry. Th17 cells were then isolated from untreated and HAART-treated HIV-infected individuals, and STAT3 phosphorylation (pSTAT3) in response to IL-23 was examined. Expression of the IL-23 receptor protein IL23R on Th17 cells was examined by flow cytometry. Results: In vitro HIV infection significantly inhibited IL-17 production in response to TCR and mitogenic stimulation. In vitro HIV infection also significantly reduced IL-23-induced pSTAT3 and expression of STAT3 and RORC mRNA. Th17 cells isolated from untreated and HAART-treated HIV-infected individuals showed complete loss of IL-23 responsiveness. IL-6 induced pSTAT3 was unaffected by in vitro and in vivo infection, suggesting that HIV infection results in specific inhibition of IL-23 signalling. Expression of the IL-23 receptor protein IL23R was comparable between HIV-seronegative controls, untreated, and HAART-treated HIV-infected individuals. Conclusions: These results demonstrate that in vitro and in vivo HIV infection results in impaired IL-23 signalling which is not reversed by HAART and is not a result from reduced receptor expression, demonstrating that HIV interferes with IL-23-activated signalling pathways. These findings may explain the inability of HAART to restore Th17 frequency and function and the resulting persistent chronic immune activation observed in HIV-infected individuals.